loading
Achilles Therapeutics Plc Adr stock is traded at $1.05, with a volume of 88,239. It is up +0.00% in the last 24 hours and up +5.00% over the past month. Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.
See More
Previous Close:
$1.05
Open:
$1.04
24h Volume:
88,239
Relative Volume:
0.14
Market Cap:
$42.32M
Revenue:
-
Net Income/Loss:
$-63.97M
P/E Ratio:
-0.5833
EPS:
-1.8
Net Cash Flow:
$-62.91M
1W Performance:
+0.96%
1M Performance:
+5.00%
6M Performance:
+10.78%
1Y Performance:
+29.63%
1-Day Range:
Value
$1.03
$1.06
1-Week Range:
Value
$0.9901
$1.12
52-Week Range:
Value
$0.63
$1.76

Achilles Therapeutics Plc Adr Stock (ACHL) Company Profile

Name
Name
Achilles Therapeutics Plc Adr
Name
Phone
-
Name
Address
-
Name
Employee
215
Name
Twitter
Name
Next Earnings Date
2024-12-11
Name
Latest SEC Filings
Name
ACHL's Discussions on Twitter

Compare ACHL with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
ACHL 1.05 42.32M 0 -63.97M -62.91M -1.80
VRTX 467.34 119.83B 10.63B -479.80M -1.35B 13.33
REGN 760.66 83.28B 13.85B 4.65B 3.32B 35.06
ARGX 566.22 33.74B 1.86B -40.29M -1.28B -4.16
ALNY 230.69 30.38B 2.09B -332.26M 16.06M -4.14
BNTX 101.41 24.08B 3.30B -501.07M 1.03B 11.54

Achilles Therapeutics Plc Adr Stock (ACHL) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-26-21 Initiated BofA Securities Buy
Apr-26-21 Initiated Chardan Capital Markets Buy
Apr-26-21 Initiated JP Morgan Underweight
Apr-26-21 Initiated Oppenheimer Outperform
Apr-26-21 Initiated Piper Sandler Overweight

Achilles Therapeutics Plc Adr Stock (ACHL) Latest News

pulisher
Nov 14, 2024

Achilles Therapeutics Reports Third Quarter 2024 Financial Results - GlobeNewswire Inc.

Nov 14, 2024
pulisher
Oct 16, 2024

80+ Pharma Companies Unite to Shape the Future of RNA-Based Therapeutics | DelveInsight - 新浪香港

Oct 16, 2024
pulisher
Sep 23, 2024

ACHL’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Sep 23, 2024
pulisher
Sep 23, 2024

Check Out Achilles Therapeutics Plc ADR (ACHL)’s Trade Data Rather Than the Analysts’ Views - SETE News

Sep 23, 2024
pulisher
Sep 23, 2024

Is Achilles Therapeutics (ACHL) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Sep 23, 2024
pulisher
Sep 20, 2024

why Achilles Therapeutics Plc ADR [ACHL] is a Good Choice for Investors After New Price Target of $1.25 - The DBT News

Sep 20, 2024
pulisher
Sep 20, 2024

What Analysts Were Expecting After PowerFleet Inc (NASDAQ: AIOT) rose 2.40% - Stocks Register

Sep 20, 2024
pulisher
Sep 20, 2024

Achilles Thera shifts focus to new cancer treatment avenues - The Pharma Letter

Sep 20, 2024
pulisher
Sep 19, 2024

Achilles Therapeutics ends TIL-based cancer therapy trials - Investing.com

Sep 19, 2024
pulisher
Sep 19, 2024

You Should Read This Analysis Before Investing in Achilles Therapeutics Plc ADR (NASDAQ:ACHL) - US Post News

Sep 19, 2024
pulisher
Sep 19, 2024

Achilles stock climbs on strategic focus (NASDAQ:ACHL) - Seeking Alpha

Sep 19, 2024
pulisher
Sep 19, 2024

Achilles Therapeutics Announces Strategic Update - Yahoo Finance

Sep 19, 2024
pulisher
Aug 14, 2024

Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates - GlobeNewswire

Aug 14, 2024
pulisher
Jun 27, 2024

Immunovant (IMVT) Up More Than 20% in Past 3 Months: Here's Why - Yahoo New Zealand News

Jun 27, 2024
pulisher
Jun 24, 2024

Kodiak Sciences (KOD) Rises 60% in Past 3 Months: Here's Why - Yahoo Sport Australia

Jun 24, 2024
pulisher
Jun 19, 2024

Achilles Therapeutics Plc ADR (ACHL) Clearly Signals Buy-Into the Stock: Don't ignore the signals – Sete News - SETE News

Jun 19, 2024
pulisher
Jun 04, 2024

Amgen's (AMGN) Lumakras Meets Goal in New Lung Cancer Study - Yahoo Lifestyle UK

Jun 04, 2024
pulisher
May 25, 2024

Blueprint Medicines' (BPMC) Ayvakit Meets Goal in PIONEER Study - Yahoo Movies UK

May 25, 2024
pulisher
May 24, 2024

Waters (WAT) Walk-Up Solutions Boost Bioprocess Development - Yahoo Lifestyle UK

May 24, 2024
pulisher
May 22, 2024

Achilles Therapeutics and Arcturus team up for cancer vaccine By Investing.com - Investing.com

May 22, 2024
pulisher
May 22, 2024

Achilles Therapeutics Announces Research Collaboration with Arcturus Therapeutics to Explore Second-Generation ... - GlobeNewswire

May 22, 2024
pulisher
May 22, 2024

Achilles Therapeutics Announces Research Collaboration with - GlobeNewswire

May 22, 2024
pulisher
May 17, 2024

Achilles Therapeutics faces Nasdaq delisting over share price - Investing.com

May 17, 2024
pulisher
May 17, 2024

Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement - GlobeNewswire

May 17, 2024
pulisher
May 12, 2024

Horizon (HZNP) Inks Collaboration Deal with Q32 Bio for ADX-914 - Yahoo New Zealand News

May 12, 2024
pulisher
May 09, 2024

Achilles Therapeutics Plc ADR's Shares Reel: -0.12% Quarterly Revenue Decline Amid 37.75M Market Cap – Invest ... - The InvestChronicle

May 09, 2024
pulisher
May 08, 2024

Achilles Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire

May 08, 2024
pulisher
Apr 04, 2024

Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC ... - GlobeNewswire

Apr 04, 2024
pulisher
Feb 09, 2024

Is ImmunoGen (IMGN) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Feb 09, 2024
pulisher
Feb 05, 2024

Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference - GlobeNewswire

Feb 05, 2024
pulisher
Jan 24, 2024

Is Acadia Healthcare (ACHC) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Jan 24, 2024
pulisher
Nov 13, 2023

Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights - GlobeNewswire

Nov 13, 2023
pulisher
Sep 20, 2023

Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation - Quantisnow

Sep 20, 2023
pulisher
Nov 01, 2022

What Makes Achilles Therapeutics PLC Sponsored ADR (ACHL) a New Buy Stock - Yahoo Finance

Nov 01, 2022
pulisher
Sep 09, 2022

Apellis (APLS) Up More Than 60% in Past 3 Months: Here's Why - Nasdaq

Sep 09, 2022
pulisher
Sep 05, 2022

Immuneering (IMRX) Files IND for Cancer Candidate IMM-1-104 - Yahoo Finance

Sep 05, 2022
pulisher
Aug 22, 2022

Axsome (AXSM) Soars on FDA Nod for Depression Drug, Auvelity - Yahoo Finance Australia

Aug 22, 2022
pulisher
Jun 30, 2022

Achilles Therapeutics Appoints James Taylor as Chief Business Officer and Cassian Yee, MD to Scientific Advisory Board - GlobeNewswire

Jun 30, 2022
pulisher
Dec 24, 2021

Achilles Therapeutics PlcADR Shares Close the Day 10.1% HigherDaily Wrap - Nasdaq

Dec 24, 2021
pulisher
Mar 30, 2021

Achilles Therapeutics Announces Pricing of Initial Public Offering - GlobeNewswire

Mar 30, 2021
pulisher
Jul 27, 2011

ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN

Jul 27, 2011

Achilles Therapeutics Plc Adr Stock (ACHL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$18.94
price up icon 3.39%
$75.94
price down icon 0.01%
$39.03
price up icon 6.21%
$360.04
price down icon 0.87%
$187.60
price down icon 1.35%
$99.70
price down icon 0.06%
Cap:     |  Volume (24h):